Nebulizers: We do not recommend the use of heat-based vaporizers or any enhanced high-pressure nebulizers with this product Doctors have reported mixed results such as GSH breakdown and clogging
Ratner R, Han J, Nicewarner D, Yushmanova I, Hoogwerf BJ, Shen L: Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes
The efficacy of once-weekly subcutaneous semaglutide and once-daily oral semaglutide has been investigated in the global SUSTAIN and PIONEER phase III clinical trial programs in a range of clinical settings, including early T2D managed with diet and exercise only, more established T2D uncontrolled on one to three oral antidiabetic drugs, and advanced disease treated with insulin
The vast majority of weight loss injection side effects are mild and temporary
These changes contribute to healthier eating habits, which are essential for long-term success
Investigational Status Retatrutide is investigational and not FDA-approved as of April 2026